FIELD: medicine. SUBSTANCE: method involves determining antioxidation activity in lacrimal fluid and blood serum. Lacrimal fluid antioxidation activity being equal to or less than 102 mcM and ratio being equal to or less than 0.3, exacerbation or lingering uveitis process is to be predicted. Lacrimal fluid antioxidation activity being equal to or greater than 175 mcM and the ratio being equal to or greater than 0.7, favorable development course or remission period is to be predicted. EFFECT: reliable prognosis. _
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RISK OF RETINAL DETACHMENT DEVELOPMENT IN CASES OF PERIPHERAL AND POSTERIOR UVEITES IN CHILDREN | 2000 |
|
RU2172957C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSES OF UVEITES ASSOCIATED WITH RHEUMATIC DISEASES IN CHILDREN, ACCOMPANYING BASIC THERAPY BY TUMOUR NECROSIS FACTOR ALPHA | 2011 |
|
RU2479848C1 |
| METHOD FOR PREDICTING PROGRESSING MYOPIA DEVELOPMENT IN CHILDREN | 1997 |
|
RU2133036C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
| METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS | 2005 |
|
RU2298188C1 |
| METHOD FOR PREDICTING COMPLICATIONS AFTER ANTIGLAUCOMATOUS OPERATION IN CASE OF INBORN GLAUCOMA | 2003 |
|
RU2242003C1 |
| WAY OF FORECASTING OF ADVANCE OF PROLIFERATIVE COMPLICATIONS AT PERIPHERIC UVEITES AT CHILDREN | 2008 |
|
RU2362172C1 |
| METHOD FOR EVALUATING ANTI-INFLAMMATORY ACTIVITY OF CYTOKINETIC AGENTS | 1999 |
|
RU2150113C1 |
| METHOD FOR PREDICTING GLAUCOMA DEVELOPMENT COURSE | 1998 |
|
RU2139538C1 |
| METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
